| |
 |
|
Class Information
Number: 435/91.32
Name: Chemistry: molecular biology and microbiology > Micro-organism, tissue cell culture or enzyme using process to synthesize a desired chemical compound or composition > Preparing compound containing saccharide radical > Preparing nitrogen-containing saccharide > N-glycoside > Nucleotide > Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) > Polynucleotide contains only ribonucleotide monomers > Prepared from virus, prokaryotic acid
Description: Processes wherein the desired RNA results from the culturing of a virus, prokaryote, or eukaryote.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7566532 |
Methods for detecting retroviruses |
Jul. 28, 2009 |
| 7524651 |
Assay methods for detection of a virus in an avian tissue sample |
Apr. 28, 2009 |
| 7504227 |
Drug targets for the treatment of neurodegenerative disorders |
Mar. 17, 2009 |
| 7501129 |
Vectors comprising guinea pig CMV regulatory elements |
Mar. 10, 2009 |
| 7435539 |
Typing of human enteroviruses |
Oct. 14, 2008 |
| 7179457 |
Modified nodavirus RNA for gene delivery |
Feb. 20, 2007 |
| 7166287 |
Viral agent |
Jan. 23, 2007 |
| RE39282 |
Nucleic acid derivatives |
Sep. 12, 2006 |
| 6958211 |
Methods of assessing HIV integrase inhibitor therapy |
Oct. 25, 2005 |
| 6956117 |
Self-replicating RNA molecule from hepatitis C virus |
Oct. 18, 2005 |
| 6908762 |
Method of preparing a eukaryotic viral vector |
Jun. 21, 2005 |
| 6887707 |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
May. 3, 2005 |
| 6869780 |
Nodavirus-like DNA expression vector and uses therefor |
Mar. 22, 2005 |
| 6866853 |
Interferon inducing genetically engineered attenuated viruses |
Mar. 15, 2005 |
| 6849431 |
Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
Feb. 1, 2005 |
| 6846621 |
Typing of human enteroviruses |
Jan. 25, 2005 |
| 6818209 |
Retroviral delivery system |
Nov. 16, 2004 |
| 6803194 |
Use of ribozymes for functionating genes |
Oct. 12, 2004 |
| 6723321 |
Autoinducer synthase modulating compounds and uses thereof |
Apr. 20, 2004 |
| 6706874 |
Self-replicating RNA molecule from hepatitis C virus |
Mar. 16, 2004 |
| 6699987 |
Formulations and method for isolating nucleic acids from optional complex starting material and subsequent complex gene analytics |
Mar. 2, 2004 |
| 6660264 |
Treatment of intracellular infection |
Dec. 9, 2003 |
| 6630300 |
Oligonucleotides and method for characterizing and detecting Genogroup II type small round structured virus |
Oct. 7, 2003 |
| 6613516 |
Preparation of nucleic acid samples |
Sep. 2, 2003 |
| 6596268 |
Viruses for the treatment of cellular proliferative disorders |
Jul. 22, 2003 |
| 6573092 |
Method of preparing a eukaryotic viral vector |
Jun. 3, 2003 |
| 6514694 |
Methods for the detection of encysted parasites |
Feb. 4, 2003 |
| 6392124 |
Infectious vectors and clones of plants derived from the turnip mosaic virus (TUMV) |
May. 21, 2002 |
| 6331417 |
Detection and quantification of human herpes virus 7 by enzymic amplification |
Dec. 18, 2001 |
| 6284249 |
Fusion polypeptide having the C protein and E1 protein of hepatitis C virus |
Sep. 4, 2001 |
| 6280974 |
Recombinant feline coronavirus S proteins |
Aug. 28, 2001 |
| 6245528 |
Latent baculovirus expression system |
Jun. 12, 2001 |
| 6218105 |
High throughput papilloma virus in vitro infectivity assay |
Apr. 17, 2001 |
| 6197944 |
DNA molecules stabilized by modifications of the 3'-terminal phosphodiester linkage |
Mar. 6, 2001 |
| 6063628 |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
May. 16, 2000 |
| 6037126 |
Compositions, methods, kits and apparatus for determining the presence or absence of protein component of telomerase enzyme |
Mar. 14, 2000 |
| 5973137 |
Low pH RNA isolation reagents, method, and kit |
Oct. 26, 1999 |
| 5962274 |
Viral vector directed to predetermined target cells |
Oct. 5, 1999 |
| 5959092 |
HCV isolates |
Sep. 28, 1999 |
| 5942389 |
Genes and genetic elements associated with sensitivity to cisplatin |
Aug. 24, 1999 |
| 5882852 |
Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates |
Mar. 16, 1999 |
| 5869634 |
Method of making an RNA particle for use in cleaving nucleic acid molecules and inserting a nucleic acid molecule into the cleavage site |
Feb. 9, 1999 |
| 5856157 |
.DELTA..sup.9 14:0-ACP fatty acid desaturase and gene therefor |
Jan. 5, 1999 |
| 5780272 |
Intron-mediated recombinant techniques and reagents |
Jul. 14, 1998 |
| 5721119 |
Ryegrass pollen allergen |
Feb. 24, 1998 |
| 5712088 |
Methods for detecting Hepatitis C virus using polynucleotides specific for same |
Jan. 27, 1998 |
| 5674723 |
Nucleic acid molecules which immortalize human or animal cells and uses thereof |
Oct. 7, 1997 |
| 5639600 |
Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
Jun. 17, 1997 |
| 5629413 |
Oligonucleotides with activity against human immunodeficiency virus |
May. 13, 1997 |
| 5595869 |
Diagnostic methods for detecting lymphomas in humans |
Jan. 21, 1997 |
|
|
|
